CHF 3,008.9 million
CHF 177.8 million
CHF 136.0 million
CHF 34.7 million
6,131 (4,657 full-time equivalents)
Galenica Santé concentrated its strengths in 2016 and increased sales by 3.2% to CHF 3,008.9 million. All Business sectors performed well in a challenging market, despite pressure on drug prices, consumer tourism outside Switzerland and a relatively weak flu season.
One of Galenica Santé’s central objectives is to increase efficiency. To this end, cooperation both within and between the three Business sectors will be further promoted and common processes more closely coordinated.